A pleasure to sit down with @TargetedOnc and talk about how important conducting clinical trials in community oncology settings is. So many opportunities to accelerate advancements for patients. So fortunate I get to do this work every day at @SarahCannonDocs @SCRIOncology
Krish Patel
@KrishPatelMD
Executive Director Hematologic Cancer Research @SarahCannonDocs @SCRIOncology #Duke alum. Tweets my own, not medical advice. #cll #lymsm
322 Following 962 Followers 400 Posts
Latest posts 5
Looking forward to a really engaging EHA and then post EHA discussion on lots of amazing new data to highlight in hematology! @SarahCannonDocs @SCRIOncology
#lymsm #heme #EHA2026 #research
#lymsm #heme #EHA2026 #research
REGISTER for our Post-EHA 2026 Highlights ๐ฉธView quoted post on X
Webinar series by VJHemOnc featuring presentations & discussions on selected abstracts from the 31st Congress of the European Hematology Association (EHA)
๐ Webinar series
๐๏ธ 23 June-2nd July 2026
Covering:
๐ Lymphoma - Chaired by: @KrishPatelMD
๐ MPNs - Chaired by: @harrisoncn1
๐ AML - Chaired by: @Daver_Leukemia
๐ Myeloma - Chaired by: Dr Karthik Ramasamy
๐ MDS - Chaired by: @Dr_AmerZeidan
๐ CLL - Chaired by: Dr Alexey Danilov
Agendas coming soon! ๐
Secure your spot ๐ ๐ vjhemonc.com/event/post-ehaโฆ
Excited to join a stellar crew of faculty in Nashville for this exciting meeting!
Excited to highlight faculty member Dr. @KrishPatelMD, Director of Lymphoma Research at Sarah Cannon Research Institute and expert medical oncologist at SCRI Oncology Partners in Nashville! With his focus on novel therapeutics, cellular therapies, and clinical trials for lymphomas and CLL, he's delivering game-changing insights to #NashvilleHeme26. FREE registration is still open for this 2-day CE-accredited conference, Feb 26-28, 2026. Secure your spot with code FREECME and join over 60 top experts: na2.hubs.ly/H03qYDn0 #Hematology #CMEView quoted post on X
Fabulous talk on challenges and opportunities in trials for Cell Tx in GI Malignancies from @MeredithPelster @SarahCannonDocs #CellTx #GIOnc #SeattleCT25
Incredible work by one of the best, congrats @niravshahmd !
Now two multicenter studies with this construct in Europe (2nd line DLBCL) and US (3rd line DLBCL). Thanks to all the people who helped along the way @MCWCancerCenter @MediHumdani @timfenske @Phari among others. Hope to one day see this product approved for pts across the world!View quoted post on X